Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Active not recruiting 2Recruiting 1Enrolling by invitation 1

Sponsor Class

NIH 3OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Classical hematology 20Myeloid 9Other hematologic neoplasm 4Sarcoma 1Plasma cell 1Other 1Lymphoid 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 874Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Hematologic Neoplasms 462Leukemia, Lymphocytic, Chronic, B-Cell 388Leukemia 328Myelodysplastic Syndromes 324Lymphoma 203Lymphoma, Non-Hodgkin 191Multiple Myeloma 145Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Recurrence 136Neoplasms 133Leukemia, Myelomonocytic, Chronic 110Burkitt Lymphoma 92Lymphoma, Mantle-Cell 91Lymphoma, Follicular 91Lymphoma, Large B-Cell, Diffuse 88Myeloproliferative Disorders 84Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 81Leukemia, Biphenotypic, Acute 79Lymphoma, B-Cell, Marginal Zone 75Hodgkin Disease 72Lymphoma, B-Cell 64Waldenstrom Macroglobulinemia 54Primary Myelofibrosis 53Leukemia, B-Cell 50Anemia, Refractory, with Excess of Blasts 45Leukemia, Myeloid, Chronic-Phase 40Hematologic Diseases 37Lymphoma, T-Cell 32

Interventions

ibrutinib 1fludarabine phosphate 1Rituximab 1Pharmacogenomic Testing 1Lenalidomide 1Epoetin Alfa 1Cyclophosphamide 1CT-P10 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Anemia × Other hematologic neoplasm × 1 year × Clear all
NCT00001620 2026-05-29

Screening for Hematology Branch Protocols

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
10,000 enrolled
Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT00843882 2026-05-29

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

National Cancer Institute (NCI)

Phase 3 Active not recruiting
247 enrolled 19 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT02048813 2026-05-29

Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
529 enrolled 12 charts 1 FDA
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07328191 2026-02-12

Q-TRANS

Centre Hospitalier Universitaire de Nice

Phase NA Recruiting
52 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡